Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ernest Moore
University of Colorado Denver, Department: Surgery
Should you be removed from our database? Contact us at [email protected]. Read more below.
Thrombo Therapeutics, Inc.
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)
Dr. Ernest Moore has a significant financial interest due to his role as an equity owner and inventor-intellectual property rights owner with Thrombo Therapeutics, Inc. Thrombo Therapeutics, Inc. holds licenses related to some of the assays used in the following human subjects protocols (the protocols), which are partially funded by RM1GM131968.
Thrombo Therapeutics, Inc. assays are used for research purposes only. The data from the tests is not accessible for the clinical care providers and does not affect patient care. The results of Thrombo Therapeutics, Inc. assays will not be used for any clinical decision or research subject assignment. Currently, there is no plan to submit Thrombo Therapeutics, Inc. assays data to the FDA
Resuscitation Strategies for Achieving Thrombo-inflammatory Homeostasis
NARRATIVE Hemorrhage after trauma is a leading cause of loss of productive lives. However, such severe injury must be staunched with immediate resuscitation, within a few golden hours. We have forged a unique team of scientists and clinicians to develop personalized resuscitation that will provide hemostasis and decreased thrombo- inflammation simultaneously.
Filed on July 10, 2019.
Tell us what you know about Ernest Moore's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Ernest Moore filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Ernest Eugene Moore | University of Colorado Denver | Conflict of Interest | Thormbo Therapeutics Inc. | Value cannot be readily determined |
| Ernest Eugene Moore | University of Colorado Denver | Conflict of Interest | Thormbo Therapeutics Inc. | Value cannot be readily determined |
| Ernest Moore | University of Colorado Denver | Conflict of Interest | Thrombo Therapeutics, Inc. | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.